Honkamp Krueger Financial Services Inc. cut its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 6.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 7,284 shares of the pharmacy operator’s stock after selling 514 shares during the quarter. Honkamp Krueger Financial Services Inc.’s holdings in Walgreens Boots Alliance were worth $429,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in the company. Opus Capital Group LLC raised its holdings in Walgreens Boots Alliance by 46.9% in the third quarter. Opus Capital Group LLC now owns 8,853 shares of the pharmacy operator’s stock valued at $490,000 after acquiring an additional 2,828 shares in the last quarter. Voya Financial Advisors Inc. raised its holdings in Walgreens Boots Alliance by 8.7% in the third quarter. Voya Financial Advisors Inc. now owns 16,420 shares of the pharmacy operator’s stock valued at $893,000 after acquiring an additional 1,319 shares in the last quarter. Penserra Capital Management LLC acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $985,000. IHT Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 12.5% in the third quarter. IHT Wealth Management LLC now owns 17,686 shares of the pharmacy operator’s stock valued at $979,000 after acquiring an additional 1,966 shares in the last quarter. Finally, Wealthsource Partners LLC raised its holdings in Walgreens Boots Alliance by 7.6% in the third quarter. Wealthsource Partners LLC now owns 10,249 shares of the pharmacy operator’s stock valued at $567,000 after acquiring an additional 727 shares in the last quarter. Institutional investors and hedge funds own 60.37% of the company’s stock.
Shares of NASDAQ:WBA opened at $54.43 on Thursday. The stock has a market capitalization of $47.89 billion, a price-to-earnings ratio of 9.09, a price-to-earnings-growth ratio of 1.33 and a beta of 0.90. Walgreens Boots Alliance Inc has a 1-year low of $49.03 and a 1-year high of $74.94. The company’s fifty day moving average is $58.07 and its two-hundred day moving average is $55.66. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.31 and a current ratio of 0.66.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, January 8th. The pharmacy operator reported $1.37 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.03). The business had revenue of $34.34 billion for the quarter, compared to analyst estimates of $34.45 billion. Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period last year, the company posted $1.46 earnings per share. Sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.87 EPS for the current fiscal year.
In related news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $63.16, for a total value of $14,801,861.80. Following the sale, the chief accounting officer now owns 13,844 shares of the company’s stock, valued at approximately $874,387.04. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 16.91% of the stock is owned by company insiders.
A number of analysts have weighed in on the stock. Bank of America reissued a “sell” rating and set a $50.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, January 2nd. Royal Bank of Canada cut shares of Walgreens Boots Alliance to a “hold” rating and set a $59.00 target price on the stock. in a report on Friday, September 27th. SunTrust Banks increased their target price on shares of Walgreens Boots Alliance from $58.00 to $60.00 and gave the stock a “hold” rating in a report on Wednesday, December 18th. ValuEngine raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Tuesday, December 3rd. Finally, Wells Fargo & Co cut shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating in a report on Wednesday, December 11th. Five equities research analysts have rated the stock with a sell rating and fifteen have given a hold rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $58.69.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: New Google Finance Tool and Screening Stocks
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.